Abbott Laboratories (BCBA:ABT)

Elevation Oncology Revenue

Abbott Laboratories had revenue of $11.14B USD in the quarter ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to $43.11B, up 5.85% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.

• Revenue (ttm): $43.11B
• Revenue Growth: +5.85%
• P/S Ratio: 5.75
• Revenue / Employee: $378.15K
• Employees: 114,000
• Market Cap: 295.40T

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.95B	1.84B	4.59%
Dec 31, 2023	40.11B	-3.54B	-8.12%
Dec 31, 2022	43.65B	578.00M	1.34%
Dec 31, 2021	43.08B	8.47B	24.47%
Dec 31, 2020	34.61B	2.70B	8.48%